PDF
(424KB)
i
This article has been updated.
A Correction to this article was published on .
i
The Original Article was published on
i
The Original Article was published on
i
This article has been updated
i
This article was retracted on
i
This article has been updated
Abstract
This study identified mutations of the idurnate-2-sulfatase (IDS) gene in a patient with Hunter syndrome, and established a basis for the diagnosis of the prenatal gene of Hunter syndrome. Urine glyeosaminoglycan (GAG) assay was used to make the preliminary diagnosis of mucopolysaccharidosis type II. Polymerase chain reaction (PCR) from dried blood spots and DNA sequencing were applied to analyze hotspot mutations in exons 9,3 and 8 of the IDS gene in the proband and his parents. A new missense mutation (T1140C) in exon 8 of the IDS gene was found by using DNA sequencing. This mutation caused a substitution of codon 339 from CTA (leucine) to CCA (praline). The patient is a hemizygote, and his mother is a heterozygote. The new missense mutation results in a change in the primary and tertiary structure of the IDS protein. It is possible that this mutation severely impairs enzymatic activity and is the underlying basis for the pathology seen in this patient with Hunter syndrome.
Keywords
Hunter syndrome, mucopolysaccharidosis type II, iduronate-2-sulfatase, gene mutation, polymerase chain reaction, DNA sequencing
Cite this article
Download citation ▾
GUO Yibin, DU Chuanshu, WANG Jingjing.
Detection of a new mutation (T1140C) in a patient with Hunter syndrome from Guangdong, China.
Front. Biol., 2007, 2 (4) : 383-386 DOI:10.1007/s11515-007-0057-8
CHANGE HISTORY
A Correction to this paper has been published:
https://doi.org
The Retraction Note was updated to reflect reception of statements of disagreement from all authors.
This article has been retracted.Please see the Retraction Notice for more detail:
https://doi.org